DRD2 and schizophrenia: The current accumulated knowledge of the biochemical properties of the A2AR-D2R heteromer offer new therapeutic possibilities for Parkinson’s disease, schizophrenia, SUD and other neuropsychiatric disorders with dysfunction of dorsal or ventral striatopallidal neurons.